Metabolic dysfunction-associated steatotic liver disease as a predictor of cognitive performance: An 11-year population-based follow-up study
Digestive and Liver Disease · 2025-05 · 57 (5) · 1035-1045
DOI: 10.1016/j.dld.2025.01.197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive and Liver Disease, 2025-05. Verfasst von Emilia Vataja und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Medicine, University of Turku, Turku, Finland. Electronic address: oevata@utu.fi. Hauptthemen laut MEDLINE: Fatty Liver, Cognition, Cognitive Dysfunction, Cognition Disorders. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Suomen Lääketieteen Säätiö, Fondazione Diabete Ricerca, Turun Yliopistollinen Keskussairaala.
Abstract (Originalsprache)
BACKGROUND: Prevalent manifestation of metabolic dysfunction, metabolic dysfunction-associated steatotic liver disease (MASLD), has been associated with poorer cognitive performance and greater decline in cognitive functions. AIM: The aim of this study was to analyze whether MASLD, measured by fatty-liver-index (FLI), predicts decline in cognitive performance during 11 years. METHODS: This study was based on the Finnish nationwide, population-based Health 2000 Health Examination Survey and its follow-up, Health 2011 Survey. Cognitive performance was assessed with verbal fluency, word-list learning (WLL), delayed word-list recall (both at baseline and at follow-up), and with simple reaction time and visual choice reaction time tests (only at baseline). Statistical analyses were performed using multivariate linear regression adjusted for age, sex, education, APOE ε4 genotype, hypercholesterolemia, diabetes mellitus, hypertension, depressive symptoms, physical activity smoking status, C-reactive protein and HOMA of insulin resistance. RESULTS: Cross-sectionally, 5,139 (mean age 52.3 years) and longitudinally, 3,143 (mean age 49.3 years) participants were examined. Cross-sectionally, no associations between FLI and cognitive performance were found in the adjusted models. Longitudinally, baseline FLI > 60 predicted poorer WLL (p < 0.005) and a decline in WLL from baseline to follow-up (p < 0.04). CONCLUSIONS: Our results suggest that MASLD is an independent predictor of decline in a test measuring working memory and learning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Geriatric Medicine, University of Turku, Turku, Finland. Electronic address: oevata@utu.fi.
- Department of Geriatric Medicine, University of Turku, Turku, Finland; Division of Clinical Geriatrics, NVS, Karolinska Institutet, Stockholm, Sweden.
- Turku PET Centre, University of Turku, Turku, Finland; Turku PET Centre, University Hospital of Turku, Turku, Finland; InFLAMES Research Flagship Center, University of Turku, Turku, Finland.
- Finnish Institute for Health and Welfare, Helsinki, Finland.
- Department of Transplantation and Liver Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
- Department of Geriatric Medicine, University of Turku, Turku, Finland; Turku PET Centre, University of Turku, Turku, Finland; Turku PET Centre, University Hospital of Turku, Turku, Finland; Department of Geriatrics, Tur…
Förderung
- Suomen Lääketieteen Säätiö
- Fondazione Diabete Ricerca
- Turun Yliopistollinen Keskussairaala
- Sigrid Juséliuksen Säätiö
Zitieren
APA
Vataja, E., Viitanen, M., Rinne, J. O., Lehtisalo, J., Erlund, I., Ngandu, T., Koskinen, S., Åberg, F., Jula, A., & Ekblad, L. (2025). Metabolic dysfunction-associated steatotic liver disease as a predictor of cognitive performance: An 11-year population-based follow-up study. Digestive and Liver Disease, 57(5), 1035-1045. https://doi.org/10.1016/j.dld.2025.01.197
Vancouver
Vataja E, Viitanen M, Rinne JO, Lehtisalo J, Erlund I, Ngandu T, et al. Metabolic dysfunction-associated steatotic liver disease as a predictor of cognitive performance: An 11-year population-based follow-up study. Digestive and Liver Disease. 2025;57(5):1035-1045. doi:10.1016/j.dld.2025.01.197
BibTeX
@article{Vataja2025,
author = {Vataja, Emilia and Viitanen, Matti and Rinne, Juha O and Lehtisalo, Jenni and Erlund, Iris and Ngandu, Tiia and Koskinen, Seppo and Åberg, Fredrik and Jula, Antti and Ekblad, Laura},
title = {Metabolic dysfunction-associated steatotic liver disease as a predictor of cognitive performance: An 11-year population-based follow-up study},
journal = {Digestive and Liver Disease},
year = {2025},
volume = {57},
number = {5},
pages = {1035--1045},
doi = {10.1016/j.dld.2025.01.197}
}
EUVIMED